Navigation Links
Sofosbuvir: Indication of added benefit for specific patients
Date:5/2/2014

from studies in which the respective comparator therapy was tested in at least one study arm and compared these in a "historical" comparison.

It included both randomized controlled trials (RCTs) and one-arm studies on the sofosbuvir side, but only RCTs on the comparator side. It justified this by claiming that it wanted to reduce the number of hits of its literature search. However, the database for the comparison was different because of this and the comparison itself was therefore unsuitable. A first literature search by IQWiG showed that a number of studies were not considered in the dossier.

One direct comparative study on genotype 2

The situation was different for genotype 2: Here, the manufacturer cited an open-label RCT (FISSION), in which treatment-naive (i.e. non-pretreated) adults with genotype 2 and 3 hepatitis C infection were investigated. In the intervention arm, they received 12 weeks of sofosbuvir plus ribavirin, and in the control arm, they received 24 weeks of peginterferon alfa plus ribavirin.

Hence sofosbuvir was administered in compliance with the approval only for the therapeutic indication genotype 2; and, as a result, only these data were evaluable for the benefit assessment. For genotype 3, the Summary of Product Characteristics (SPC) specifies a treatment duration of 24 weeks. The manufacturer itself did not consider the FISSION study in its dossier for patients with genotype 3.

High risk of biased results

Overall, IQWiG assessed the risk of bias of the FISSION study as high. The main reason was that the manufacturer only included those participants in the analysis who had received at least one dose of the medication they were randomized to. However, particularly in the control arm, where not the new drug, but conventional drugs were administered, some patients refused to have their planned treatment.

This is a general problem of open-label studies, where it is kn
'/>"/>

Contact: Dr. Anna-Sabine Ernst
presse@iqwig.de
49-022-135-6850
Institute for Quality and Efficiency in Health Care
Source:Eurekalert

Page: 1 2 3 4 5

Related medicine news :

1. Finnish research to revolutionise indications for knee surgery
2. Southwest Skin and Cancer Institute Employs Botox for New Indications
3. Global Vaccine Market Trends and Disease Indications Analysis with 2022 Forecasts in New Research Report at RnRMarketResearch.com
4. Apixaban in atrial fibrillation: Indications of considerable added benefit
5. Aflibercept in colorectal cancer: Indication of minor added benefit
6. Global Critical Care Market Will Reach $3.2 Billion in 2019 - Growth from Factor Concentrates, New Indications and Increasing Demand for Albumin in Asia-Pacific
7. Indication of considerable added benefit of vemurafenib in advanced melanoma
8. Antibody-coated stents: Indication of disadvantages
9. Abiraterone: Indication of considerable added benefit in certain patients
10. Turoctocog alfa in patients with hemophilia A: Added benefit not proven
11. Geriatric health professionals experience added burden when caring for own family members
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2015)... Two addiction experts from ... Pei on a CNBC radio podcast for a ... on KCAA AM 1050, the podcast features Tim Salyer, ... therapist, as they discuss current statistics on drug and ... 23.5 million Americans. The program, titled “Addiction, Self-Hatred, Hope ...
(Date:5/26/2015)... May 26, 2015 Relias Learning ... for the health and human services market, announces expansion ... demand. After strong attendance and participation in 2014, they ... give their annual user conference an exciting new facelift. ... to come together and discuss best practices, share their ...
(Date:5/26/2015)... 2015 Synthetic cannabinoids attempt to ... article published by International Business Times ... Spice, and black mamba) causes unpredictable medical and ... substances make it nearly impossible for medical doctors ... the substance due to the frequency in which ...
(Date:5/26/2015)... Pasadena porcelain veneers dentist, Dr. Marine ... treatments. Cosmetic dentistry is becoming increasingly popular in today’s ... committed to providing you with the highest level of ... a smile of a lifetime … We work with ... change your life,” explains Dr. Martirosyan’s team. “Giving you ...
(Date:5/26/2015)... Indosoft, Inc ., developer of ... DMi Partners contact center to Q-Suite 5.8 call ... contact center ACD system to drop Asterisk 1.4 support. ... trunk features as diversion headers, added Lyra support via ... to warm transfers to improve information handling ...
Breaking Medicine News(10 mins):Health News:Anaheim Lighthouse Staff Joined Dr. Marissa Pei’s in a Conversation on Drug and Alcohol Addiction 2Health News:Anaheim Lighthouse Staff Joined Dr. Marissa Pei’s in a Conversation on Drug and Alcohol Addiction 3Health News:Relias Learning Expands User Groups and Industry Influence 2Health News:Relias Learning Expands User Groups and Industry Influence 3Health News:Synthetic Cannabinoids Can Cause Psychotic Episodes; Doctors at a Loss for Treatment 2Health News:Synthetic Cannabinoids Can Cause Psychotic Episodes; Doctors at a Loss for Treatment 3Health News:Pasadena Porcelain Veneers Expert, Marine Martirosyan DDS, is Now Offering Complimentary Dental Cleaning with Cosmetic Treatments 2Health News:DMi Partners Upgrades to Indosoft Q-Suite 5.8 2Health News:DMi Partners Upgrades to Indosoft Q-Suite 5.8 3
... at the Stanford University School of Medicine have devised a ... virtually separate a whole-blood sample into its different cell types ... of those cell types. In a study to be ... scientists reported that they had successfully used the new technique ...
... that much harder to eliminate, scientists say , SUNDAY, March ... the AIDS virus in the blood to zero, but HIV ... their pills. Now, research is giving scientists new insight into ... powers of medicine. , In a new study, researchers ...
... ... residents in hypertension therapy and sleep disorders will receive international recognition at the American ... ... work of two St. Elizabeth Internal Medicine residents in hypertension therapy and sleep disorders ...
... ... certification. Their revolutionary line of quick couplings and plastic fittings are all designed, ... ... -- Kent Systems received their Made in the USA Brand certification. Their revolutionary ...
... ... the 2010 Cinco de Mayo Half Marathon and the 12th Annual “Reaching for the Cure” ... ... Research Foundation (PCRF) announced the official sponsors for the annual “Reaching for the Cure” ...
... Age ... specialist-expert and nutritionist counselor, Rod Stanley, to give patients 1:1 attention and superior fitness ... ... expert and age management medicine icon, is boosting patient motivational levels by adding his ...
Cached Medicine News:Health News:Mathematical innovation turns blood draw into information gold mine in Stanford study 2Health News:Mathematical innovation turns blood draw into information gold mine in Stanford study 3Health News:Mathematical innovation turns blood draw into information gold mine in Stanford study 4Health News:HIV Hides Out in Bone Marrow Cells 2Health News:St. Elizabeth Medical Residents to Present Research at International Meeting, 2Health News:Kent Systems Received Made in the USA Brand Certification 2Health News:Sponsors for the 2010 Pediatric Cancer Research Foundation “Reaching for the Cure” Annual Cinco de Mayo Run/Walk Fundraising Event 2Health News:Sponsors for the 2010 Pediatric Cancer Research Foundation “Reaching for the Cure” Annual Cinco de Mayo Run/Walk Fundraising Event 3Health News:Healthy Aging Icon Ups Patient Motivational Levels, Signs His Personal Trainer To Age-Management Team 2Health News:Healthy Aging Icon Ups Patient Motivational Levels, Signs His Personal Trainer To Age-Management Team 3
(Date:5/26/2015)... Calif. , May 26, 2015  Amgen (NASDAQ: ... results from the Phase 3 OPTiM study in the ... . The data published in JCO , ... the American Society of Clinical Oncology (ASCO) in 2013 ... (DRR) in patients with unresected stage IIIB, IIIC or ...
(Date:5/26/2015)... --  Generational Equity , a leading mergers and acquisitions ... the acquisition of its client, Peaks & Plains ... , by Mi-Med Supply , headquartered in Vista, ... Peaks & Plains is the only dual ... nutritional, patient care, and housekeeping equipment to long-term care ...
(Date:5/26/2015)... 26, 2015 Clinicient Inc , ... announced the results of an industry survey of ... 759 therapists, practice owners and administrative staff completed ... need for technology and services that improve therapist ... findings, Clinicient published a free 12-page guide to ...
Breaking Medicine Technology:Pivotal Study Results Published in Journal of Clinical Oncology Showed Talimogene Laherparepvec Improved Durable Response Rates in Patients With Metastatic Melanoma 2Pivotal Study Results Published in Journal of Clinical Oncology Showed Talimogene Laherparepvec Improved Durable Response Rates in Patients With Metastatic Melanoma 3Pivotal Study Results Published in Journal of Clinical Oncology Showed Talimogene Laherparepvec Improved Durable Response Rates in Patients With Metastatic Melanoma 4Pivotal Study Results Published in Journal of Clinical Oncology Showed Talimogene Laherparepvec Improved Durable Response Rates in Patients With Metastatic Melanoma 5Pivotal Study Results Published in Journal of Clinical Oncology Showed Talimogene Laherparepvec Improved Durable Response Rates in Patients With Metastatic Melanoma 6Pivotal Study Results Published in Journal of Clinical Oncology Showed Talimogene Laherparepvec Improved Durable Response Rates in Patients With Metastatic Melanoma 7Pivotal Study Results Published in Journal of Clinical Oncology Showed Talimogene Laherparepvec Improved Durable Response Rates in Patients With Metastatic Melanoma 8Generational Equity Announces the Acquisition of Peaks & Plains Inc. by Mi-Med Supply 2Survey: Half of Physical Therapists Underbill For Their Services 2
... #4061DENVER, April 21 Scientists from the Barbara ... today at the American Association for Cancer Research,s ... a brighter future for children who suffer from ... http://www.newscom.com/cgi-bin/prnh/20071106/KARMANOSLOGO )Yubin Ge, Ph.D., and Chengzhi Xie, Ph.D., ...
... and Arisyn Therapeutics jointly announced today the successful ... Health to support the development of novel small ... virus (HCV) infection. ImQuest scientists will investigate ... ATI-0810 (Formerly PG301029) and a series of related ...
Cached Medicine Technology:Karmanos Cancer Institute Researchers Study New Drug Combinations to Treat Childhood Leukemia 2Karmanos Cancer Institute Researchers Study New Drug Combinations to Treat Childhood Leukemia 3ImQuest BioSciences Receives Phase I SBIR Grant to Develop a Novel Hepatitis C Virus Therapeutic Agent 2
Built-in convexity means added security and skin protection for recessed, retracted and flush stomas...pre-cut openings. Security and confidence achieved by the internal No-Flowback Valves and soft d...
Inquire...
Inquire...
Inquire...
Medicine Products: